vs
Side-by-side financial comparison of LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) and Waterstone Financial, Inc. (WSBF). Click either name above to swap in a different company.
Waterstone Financial, Inc. is the larger business by last-quarter revenue ($37.2M vs $31.1M, roughly 1.2× LIFECORE BIOMEDICAL, INC. \DE\). On growth, Waterstone Financial, Inc. posted the faster year-over-year revenue change (16.7% vs -4.5%). Waterstone Financial, Inc. produced more free cash flow last quarter ($23.0M vs $25.0K). Over the past eight quarters, Waterstone Financial, Inc.'s revenue compounded faster (7.1% CAGR vs -0.1%).
LIFECORE BIOMEDICAL, INC. is a biomedical firm focused on developing and manufacturing high-quality hyaluronic acid-based biomaterials. It operates three core segments: medical application products, pharmaceutical solutions, and personal care ingredients, with main markets spanning North America, Europe and the Asia-Pacific, supplying to leading medical device, pharmaceutical and cosmetic brand partners.
Waterstone Financial, Inc. is a U.S. bank holding company headquartered in Wisconsin. It offers retail and commercial banking services, residential mortgages, and wealth management solutions, primarily serving consumers and small to medium-sized businesses across the U.S. Midwest region.
LFCR vs WSBF — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $31.1M | $37.2M |
| Net Profit | $-10.0M | — |
| Gross Margin | 25.0% | — |
| Operating Margin | -9.9% | 27.0% |
| Net Margin | -32.1% | — |
| Revenue YoY | -4.5% | 16.7% |
| Net Profit YoY | -52.0% | — |
| EPS (diluted) | $-0.29 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $37.2M | ||
| Q3 25 | $31.1M | $37.0M | ||
| Q2 25 | — | $38.0M | ||
| Q1 25 | $35.2M | $29.7M | ||
| Q4 24 | $32.6M | $31.8M | ||
| Q3 24 | $24.7M | $34.1M | ||
| Q2 24 | — | $37.2M | ||
| Q1 24 | $35.7M | $32.4M |
| Q4 25 | — | — | ||
| Q3 25 | $-10.0M | $7.9M | ||
| Q2 25 | — | $7.7M | ||
| Q1 25 | $-14.8M | $3.0M | ||
| Q4 24 | $-6.6M | — | ||
| Q3 24 | $-16.2M | $4.7M | ||
| Q2 24 | — | $5.7M | ||
| Q1 24 | $15.6M | $3.0M |
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
| Q4 25 | — | 27.0% | ||
| Q3 25 | -9.9% | 26.6% | ||
| Q2 25 | — | 25.4% | ||
| Q1 25 | -25.7% | 13.1% | ||
| Q4 24 | -6.0% | 19.5% | ||
| Q3 24 | -46.9% | 17.3% | ||
| Q2 24 | — | 19.2% | ||
| Q1 24 | -2.5% | 14.7% |
| Q4 25 | — | — | ||
| Q3 25 | -32.1% | 21.4% | ||
| Q2 25 | — | 20.3% | ||
| Q1 25 | -42.0% | 10.2% | ||
| Q4 24 | -20.2% | — | ||
| Q3 24 | -65.7% | 13.9% | ||
| Q2 24 | — | 15.4% | ||
| Q1 24 | 43.8% | 9.4% |
| Q4 25 | — | $0.43 | ||
| Q3 25 | $-0.29 | $0.45 | ||
| Q2 25 | — | $0.43 | ||
| Q1 25 | $-0.47 | $0.17 | ||
| Q4 24 | $-0.25 | $0.28 | ||
| Q3 24 | $-0.53 | $0.26 | ||
| Q2 24 | — | $0.31 | ||
| Q1 24 | $0.42 | $0.16 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $18.9M | — |
| Total DebtLower is stronger | $136.0M | $412.3M |
| Stockholders' EquityBook value | $-10.5M | $349.4M |
| Total Assets | $235.2M | $2.3B |
| Debt / EquityLower = less leverage | — | 1.18× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | $18.9M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $5.4M | — | ||
| Q4 24 | $9.5M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | — | $412.3M | ||
| Q3 25 | $136.0M | $469.1M | ||
| Q2 25 | — | $465.7M | ||
| Q1 25 | $124.9M | $395.9M | ||
| Q4 24 | $111.3M | $446.5M | ||
| Q3 24 | $106.3M | $560.1M | ||
| Q2 24 | — | $660.8M | ||
| Q1 24 | $97.1M | $634.2M |
| Q4 25 | — | $349.4M | ||
| Q3 25 | $-10.5M | $345.5M | ||
| Q2 25 | — | $341.5M | ||
| Q1 25 | $2.2M | $341.4M | ||
| Q4 24 | $15.4M | $339.1M | ||
| Q3 24 | $-3.9M | $342.0M | ||
| Q2 24 | — | $334.9M | ||
| Q1 24 | $17.7M | $338.0M |
| Q4 25 | — | $2.3B | ||
| Q3 25 | $235.2M | $2.3B | ||
| Q2 25 | — | $2.3B | ||
| Q1 25 | $237.7M | $2.2B | ||
| Q4 24 | $255.4M | $2.2B | ||
| Q3 24 | $246.8M | $2.2B | ||
| Q2 24 | — | $2.3B | ||
| Q1 24 | $246.2M | $2.2B |
| Q4 25 | — | 1.18× | ||
| Q3 25 | — | 1.36× | ||
| Q2 25 | — | 1.36× | ||
| Q1 25 | 56.05× | 1.16× | ||
| Q4 24 | 7.20× | 1.32× | ||
| Q3 24 | — | 1.64× | ||
| Q2 24 | — | 1.97× | ||
| Q1 24 | 5.49× | 1.88× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $1.8M | $24.2M |
| Free Cash FlowOCF − Capex | $25.0K | $23.0M |
| FCF MarginFCF / Revenue | 0.1% | 61.9% |
| Capex IntensityCapex / Revenue | 5.6% | 3.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-16.8M | $43.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $24.2M | ||
| Q3 25 | $1.8M | $32.7M | ||
| Q2 25 | — | $-38.4M | ||
| Q1 25 | $1.2M | $26.7M | ||
| Q4 24 | $-6.1M | $48.1M | ||
| Q3 24 | $-613.0K | $74.1M | ||
| Q2 24 | — | $-39.5M | ||
| Q1 24 | $-1.4M | $-9.9M |
| Q4 25 | — | $23.0M | ||
| Q3 25 | $25.0K | $32.4M | ||
| Q2 25 | — | $-38.5M | ||
| Q1 25 | $-4.3M | $26.5M | ||
| Q4 24 | $-8.6M | $47.0M | ||
| Q3 24 | $-4.0M | $73.9M | ||
| Q2 24 | — | $-39.7M | ||
| Q1 24 | $-7.8M | $-10.3M |
| Q4 25 | — | 61.9% | ||
| Q3 25 | 0.1% | 87.5% | ||
| Q2 25 | — | -101.2% | ||
| Q1 25 | -12.1% | 89.2% | ||
| Q4 24 | -26.3% | 147.5% | ||
| Q3 24 | -16.3% | 216.9% | ||
| Q2 24 | — | -106.7% | ||
| Q1 24 | -21.8% | -31.9% |
| Q4 25 | — | 3.1% | ||
| Q3 25 | 5.6% | 0.8% | ||
| Q2 25 | — | 0.2% | ||
| Q1 25 | 15.5% | 0.9% | ||
| Q4 24 | 7.5% | 3.5% | ||
| Q3 24 | 13.9% | 0.6% | ||
| Q2 24 | — | 0.4% | ||
| Q1 24 | 17.8% | 1.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 4.13× | ||
| Q2 25 | — | -4.98× | ||
| Q1 25 | — | 8.81× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 15.67× | ||
| Q2 24 | — | -6.92× | ||
| Q1 24 | -0.09× | -3.27× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
WSBF
Segment breakdown not available.
